(Q49082528)

18 February 2018

title

High prevalence of anaemia and limited use of therapy in cancer patients: a Belgian survey (Anaemia Day 2008). (English)

1 reference

18 February 2018

author name string

Natacha Verbeke

1

1 reference

18 February 2018

Yves Beguin

2

1 reference

18 February 2018

Hans Wildiers

3

1 reference

18 February 2018

J L Canon

4

1 reference

18 February 2018

Greet Bries

5

1 reference

18 February 2018

Andre Bosly

6

1 reference

18 February 2018

Simon Van Belle

7

1 reference

18 February 2018

publication date

25 November 2010

1 reference

18 February 2018

Supportive Care in Cancer

published in

1 reference

18 February 2018

volume

20

1 reference

18 February 2018

issue

1

1 reference

18 February 2018

page(s)

23-28

1 reference

18 February 2018

https://scigraph.springernature.com/pub.10.1007/s00520-010-1045-0

exact match

0 references

cites work

The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1045-0

September 2007 Update on EORTC Guidelines and Anemia Management with Erythropoiesis-Stimulating Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1045-0

Prevalence and incidence of anemia in Japanese cancer patients receiving outpatient chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1045-0

Anemia in oncology practice: relation to diseases and their therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1045-0

Impact of erythropoietin treatment on the quality of life of oncologic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1045-0

Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1045-0

Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1045-0

Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1045-0

Treatment patterns and outcomes in the management of anaemia in cancer patients in Europe: findings from the Anaemia Cancer Treatment (ACT) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1045-0

Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group

21 January 2018

1 reference

12 December 2020

Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review

1 reference

12 December 2020

Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group.

1 reference

12 December 2020

Do erythropoietin receptors on cancer cells explain unexpected clinical findings?

1 reference

12 December 2020

The Australian Cancer Anaemia Survey: a snapshot of anaemia in adult patients with cancer

1 reference

12 December 2020

10.1007/S00520-010-1045-0

Identifiers

DOI

1 reference

18 February 2018

release_27evx2f33jhp7iw4csbgdgoyjy

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/27evx2f33jhp7iw4csbgdgoyjy

24 November 2022

mapped directly with Wikidata item

PubMed ID

21107613

1 reference

18 February 2018